Seeking Alpha

Amgen Inc. (AMGN)

  • Roadmap2Retire | Send Message 1 Sep

    Outlook for Sep 2015 $AAPL $ADM $AGU $AMGN $BNS $CNI $CVX $GE $JNJ $KMI $MGA $O $OHI $QCOM $SBUX $T $TD $VTR $WFC
      • David White | Send Message 31 Aug

        Approval Of Repatha May Give Amgen A $5B Boost. $AMGN
          • Mayer Winkler | Send Message 31 Aug

            Amgen Poised To Dominate A $32 Billion Biosimilar Market $AMGN
              • InvestingInsights | Send Message 28 Aug

                $AMGN Piper Jaffray Weighs In on Amgen, Inc. Following Repatha FDA Approval
                  • chicagomary | Send Message 28 Aug

                    $ISIS doing better last 2 days;IMO this is due to their drug for same indication as $AMGN's newly approved drug
                      • Markman Advisors | Send Message 26 Aug

                        Kyle Bass's Latest IPR Missile Ventures Into Biologics And Threatens Amgen's $5B Enbrel Drug $AMGN
                          • wilkinson99 | Send Message 26 Aug

                            Current buy orders for today $AAPL $98, $FB $79, $V $64, $AMGN $139, $TSLA $210, $XOM $68.5, $HAS $70
                            Reply (1)
                            • Jchris14 | Send Message 26 Aug
                              : you think apple will go touch $98 in the near future?
                              • DoctoRx | Send Message 3 Aug

                                A Post-Earnings Review Of Amgen, With Discussion Of The Repatha Launch $AMGN
                                  • Quantified Alpha | Send Message 31 Jul

                                    As expected, $AMGN beat analyst estimates and is benefiting today. Best risk-reward in biotech space...
                                      • Kanak Kanti De | Send Message 31 Jul

                                        Premarket Biotech Digest: Amgen Beats, GlaxoSmithKline Corruption Charges, VTv Therapeutics Flops... $AMGN
                                          Visit Seeking Alpha's
                                          AMGN vs. ETF Alternatives
                                          Company Description
                                          Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. It operates in one business segment being human therapeutics.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States